A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Saved in:
| Title: | A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma. |
|---|---|
| Authors: | Gressin R; Onco-Hematology Department, Grenoble University Hospital rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble., Daguindau N; Hematology Department, Annecy Hospital., Tempescul A; Hematology Department, Brest University Hospital., Moreau A; Pathology Department, Nantes University Hospital., Carras S; Onco-Hematology Department, Grenoble University Hospital., Tchernonog E; Hematology Department, Montpellier University Hospital., Schmitt A; Hematology Department, Cancer Institute Bergonie Bordeaux., Houot R; Hematology Department, Rennes University Hospital., Dartigeas C; Hematology Department, Tours University Hospital., Pignon JM; Hematology Department, Dunkerque Hospital., Corm S; Hematology Department, Chambery Hospital., Banos A; Hematology Department, Bayonne Hospital., Mounier C; Hematology Department, Loire Cancer Institute, Saint Etienne., Dupuis J; Lymphoid Malignancies Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil., Macro M; IHBN - Hematology Department, Caen University Hospital., Fleury J; Hematology Department, Clermont-Ferrand Cancer Institute., Jardin F; Hematology Department, Rouen University Hospital., Sarkozy C; Hematology Department, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud. INSERM 1052., Damaj G; Hematology Department, Amiens University Hospital., Feugier P; Hematology Department, Nancy University Hospital., Fornecker LM; Hematology Department, University Hospital Strasbourg., Chabrot C; Hematology Department, University Clermont-Ferrand Hospital., Dorvaux V; Hematology Department, Metz University Hospital., Bouadallah K; Hematology Department, Bordeaux University Hospital., Amorin S; Hematology Department, University Hospital Paris Saint-Louis., Garidi R; Hematology Department, Saint Quentin Hospital., Voillat L; Hematology Department, Chalon Hospital., Joly B; Hematology Department, Corbeil Hospital., Celigny PS; Hematology Department, Victor Hugo Clinic, Le Mans., Morineau N; Hematology Department, Catherine de Sienne Clinic, Nantes., Moles MP; Hematology Department, Angers University Hospital., Zerazhi H; Hematology Department, Avignon Hospital., Fontan J; Hematology Department, Besançon University Hospital., Arkam Y; Hematology Department, Mulhouse Hospital., Alexis M; Hematology Department, Orleans Hospital., Delwail V; Onco-Hematology Department, University Hospital Poitiers and INSERM, CIC 1402, Poitiers University., Vilque JP; Hematology Department, Baclesse Caen Cancer Center., Ysebaert L; Hematology Department, Toulouse University Hospital., Le Gouill S; Hematology Department, Nantes University Hospital., Callanan MB; INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble-Alpes, Institute for Advanced Biosciences, Grenoble rgressin@chu-grenoble.fr mary.callanan@chu-dijon.fr.; Unit for Innovation in Genetics and Epigenetics in Oncology, Dijon University Hospital, France. |
| Corporate Authors: | Lymphoma Study Association |
| Source: | Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. 138-146. Date of Electronic Publication: 2018 Aug 31. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
